The bottom line: Theres no need to panic
NIS2+, an optimisation of the blood-based biomarker NIS4 technology for the detection of at-risk NASH: A prospective derivation and validation study
A patient sat across from me last year six weeks into semaglutide, finally feeling her appetite shift for the first time in years and asked me something I hear in almost every follow-up: "Do I still have to watch what I eat, or does the medication handle that now?" It's a fair question
Regulation of cytokine activity Our immune system relies on chemical messengers known as cytokines to work properly
We see this in regards to reducing the pleasure-seeking around alcohol, nicotine, and potentially sex drives. The evidence surrounding changed sexual function is limited, and mixed
The percentages from the Phase 2 retatrutide trial and the Phase 3 tirzepatide trials look different, but those trials enrolled different populations under different protocols
